Intercure Ltd.
For the period ended Dec 18, 2025. Filed Dec 18, 2025.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Dec 18, 2025 · Filed Dec 18, 2025
Use the contents to explore the available documents and sections.
Contents
INTERCURE LTD
(Translation of registrant’s name into English)
85 Medinat ha-Yehudim Street
Herzliya, 4676670, Israel
Tel: +972 77 460 5012
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
On December 15, 2025, InterCure Ltd. (dba Canndoc) (the “Company”) became aware that the Bazelet group of companies, a leading producer of cannabis oil (“Bazelet”), has initiated restructuring proceedings before the Israeli District Court, including an application for a temporary stay of proceedings.
Bazelet is a service provider of the Company for production, EU-GMP-certified export, and distribution services in the Israeli market. In addition, Bazelet purchases raw materials and products from the Company from time to time.
The Company holds checks issued by Bazelet in an aggregate amount of approximately NIS 27 million, which remain outstanding during the stay of proceedings.
The Company is monitoring developments in this matter and reviewing the relevant court filings, and, in accordance with the instruction of the Company’s Board of Directors, plans to pursue appropriate legal actions to protect and preserve its rights and interests, and is evaluating collaboration with an additional packaging facility.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.